News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced BioHealing, Inc. Announces First Diabetes Patient Adherence Program for Foot Ulcer Treatment


11/3/2009 9:44:01 AM

WESTPORT, Conn.--(BUSINESS WIRE)--Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine and the maker of Dermagraft®, launched during American Diabetes Month the Heal2gether Partnership Program for diabetes patients and their physicians. Focused on patient adherence, Heal2gether aims to increase awareness and proper care of diabetic foot ulcers (DFUs), enhance the effective use of living cell technologies in treating DFUs, and encourage patients to take an active role in their healing process.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES